Results 101 to 110 of about 25,850 (210)

Corpus gastritis - Helicobacter pylori - gastrin [PDF]

, 2007
Hægt er að lesa greinina í heild sinni með því að smella á hlekkinn View/OpenOBJECTIVE: Corpus gastritis is a common diagnosis. Studies have shown that about 25% of patients that undergo gastroscopy receive this diagnosis.
Fjölnir Elvarsson, Ingi Þór Hauksson, Nick Cariglia, Þorgeir Þorgeirsson   +3 more
core  

Therapeutic regimens against infection without proton pump inhibitors in patients with corpus atrophic gastritis: a real-life single-centre longitudinal observational study

Therapeutic Advances in Gastroenterology
Background: Efficacy of eradication regimens in Helicobacter pylori (Hp) infection is commonly reported with proton pump inhibitors (PPIs). In patients with corpus atrophic gastritis, characterized by impaired acid secretion, PPI treatment is ...
Emanuele Dilaghi, Lorenzo Mosciatti, Ludovica Dottori, Irene Ligato, Gianluca Esposito, Emanuela Pilozzi, Bruno Annibale, Edith Lahner   +7 more
doaj   +1 more source

Research on Predictive Auxiliary Diagnosis Method for Gastric Cancer Based on Non-Invasive Indicator Detection

Applied Sciences
Chronic atrophic gastritis is a serious health issue beyond the stomach health problems that affect normal life. This study aimed to explore the influencing factors related to chronic atrophic gastritis (CAG) using non-invasive indicators and establish ...
Xia Zhang, Mao Zhang, Gang Wei, Jia Wang
doaj   +1 more source

Modern strategy of patient management in pre-cancer stomach diseases: diagnostic approaches and therapeutic possibilities

Лечащий Врач, 2021
Stomach cancer represents a serious medical and social problem, both for most of the countries, and for Russia. Patients with chronic atrophic gastritis or intestinal metaplasia have increased risk of stomach adenocarcinoma development.
L. B. Lazebnik, E. A. Lyalyukova
doaj  

Is the long-term use of proton pump inhibitors safe? [PDF]

, 2004
Long-term use of proton pump inhibitors (PPIs) appears safe, resulting in no clinically relevant adverse effects (strength of recommendation: B, based on nonsystematic reviews, cohort studies, or low-quality randomized controlled trials).
Malaty, Wail, Mayer, Jill Byerly, Stigleman, Sue   +2 more
core  

Gastric Cancer Mortality in a High Incidence Area: Long-term follow-up of Helicobacter pylori-related Precancerous Lesions in the General Population [PDF]

BACKGROUND: Due to a lack of clear criteria for recognizing subjects at risk of progression to gastric cancer (GC), this cohort study seeks to identify predictors of GC death in a high-risk population. METHODS: During 2000-2001, 1011 randomly selected
احمدی, عماد, اعتمادی, آرش, بابایی, مسعود, بوریری, مجید, ستوده, مسعود, شریفی, امیر هوشنگ, صمدی, فاطمه, علیمحمدیان , معصومه, نیک منش, آرش, هوشيار, افشين, پورفرضی, فرهاد, یزدانبد, عباس   +11 more
core  

Epidemiology of Peptic Ulcer Disease: Endoscopic Results of a Systematic Investigation in Iran [PDF]

BACKGROUND Peptic ulcer disease is a multifactorial health problem affecting almost all populations worldwide. Large scale population-based studies are crucial to understanding its scope and specifications in various nations.
برازنده, فرهاد, درخشان, محمدحسین, قاجاریه سپانلو, صدف, ملک زاده, رضا, پورفرضی, فرهاد, یزدانبد, عباس   +5 more
core  

Pathogenesis and potential reversibility of intestinal metaplasia − a milestone in gastric carcinogenesis

Radiology and Oncology
Non-cardia gastric cancer remains a major cause of cancer-related mortality worldwide, despite declining incidence rates in many industrialized countries.
Drnovsek Jan, Homan Matjaz, Zidar Nina, Smid Lojze M   +3 more
doaj   +1 more source

Association between Helicobacter pylori infection & atrophic gastritis

مجلة كلية الطب, 2007
Background: Helicobacter pylori (H. pylori) infection is associated with gastritis and may induce atrophic gastritis have specific circulating immunoglobulin G (IgG) antibodies.
Hayfaa S. AL-Hadithi
doaj  

Meta-analyses: Does long-term PPI use increase the risk of gastric premalignant lesions? [PDF]

, 2013
Background: Proton pump inhibitors (PPIs) are the most effective agents available for reducing acid secretion. They are used for medical treatment of various acid-related disorders.
Eslami, L., Nasseri-Moghaddam, S.
core